Measurement Issues in the Use of Cognitive Neuroscience Tasks in Drug Development for Impaired Cognition in Schizophrenia: A Report of the Second Consensus Building Conference of the CNTRICS Initiative
Journal Title: Schizophrenia Bulletin - Year , Vol 34, Issue 4
Abstract
This overview describes the goals and objectives of the second conference conducted as part of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia (CNTRICS) initiative. This second conference was informed by a series of online surveys and brought together basic and clinical scientists from academia and industry to address the concerns central to each field of research. Our goal was to develop recommendations for future research addressing the psychometric and practical challenges involved in translating paradigms from cognitive neuroscience into tasks that are feasible for use in the treatment discovery and development process. In this overview article, we describe the series of talks that were presentations at the conference. This article serves as an introduction to the set of articles included in this special issue that provide overviews and discussions of the issues raised and the recommendations made in these talks and in the subsequent discussions at the meeting. In addition, we describe the online surveys conducted in the month before the conference that were used to obtain suggestions from the field as to important task selection criteria and to generate initial benchmark goals for psychometric development for cognitive neuroscience tasks.
Authors and Affiliations
Deanna M. Barch, Cameron S. Carter, the CNTRICS Executive Committee
Keywords
Related Articles
- EP ID EP683273
- DOI 10.1093/schbul/sbn037
- Views 101
- Downloads 0
Building a Clinically Relevant Cognitive Task: Case Study of the AX Paradigm
Tasks developed for basic cognitive neuroscience are often ill suited for experimental psychopathology. The development of the expectancy variant of AX continuous performance task to test theories about context processin...
Making Progress in Schizophrenia Research
Pharmacological Interventions for Clozapine-induced Hypersalivation
Clozapine is widely used for people with schizophrenia. Agranulocytosis, weight gain, and cardiac problems are serious problems associated with clozapine use. Hypersalivation, sometimes of a gross and socially unacceptab...
Approaches for Unraveling the Joint Genetic Determinants of Schizophrenia and Bipolar Disorder
Since Emil Kraepelin proposed in 1919 that dementia praecox (schizophrenia) be differentiated from manic depression (bipolar disorder), the concept of nosological dichotomy has greatly influenced the diagnosis, treatment...
Implementation Considerations for Multisite Clinical Trials with Cognitive Neuroscience Tasks
Multisite clinical trials aimed at cognitive enhancement across various neuropsychiatric conditions have employed standard neuropsychological tests as outcome measures. While these tests have enjoyed wide clinical use an...